CAMP ▼ -0.2% - CAMP4 THERAPEUTICS CORPORATION $CAMP - CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026 CAMP4 Therapeutics declined 0.2% today ahead of a virtual analyst day scheduled for September 28, 2026, where the company plans to discuss CMP-002, its candidate for treating SYNGAP1-related disorder. The modest move suggests investors are awaiting additional clinical or development details that may be presented at the event rather than reacting sharply to the announcement itself. 08-SEP-2026 04:05 PM ET